Dr. Peter E. Friedell, MD

Dr. Friedell practices at M Health Fairview University of Minnesota Medical Center in Minneapolis, Minnesota, part of M Health Fairview.

Dr. Friedell's NPI, 1356360531, was assigned on July 19, 2006. Dr. Friedell holds Maryland license D87004.

Dr. Friedell's primary practice is M Health Fairview University of Minnesota Medical Center, at 2450 Riverside Avenue, Minneapolis, MN 55454 in Hennepin County. The practice phone is (612) 624-1765.

Dr. Friedell's primary practice is M Health Fairview University of Minnesota Medical Center in Minneapolis, Minnesota, part of M Health Fairview. Dr. Friedell is also affiliated with M Health Fairview St. John's Hospital. The medical group on file is M Health Fairview Recovery Clinic. Dmand AI also links Dr. Friedell to 3 more hospitals, 8 medical groups, 1 dialysis center and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Friedell practices, 7 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Friedell's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Friedell's licenses on file in 2 states: Maryland and Illinois.

CMS data shows 449 Medicare services from Dr. Friedell across 6 procedure codes in 2024, for 212 Medicare patients. Medicare paid $28,765 for them.

CMS counts 212 Medicare patients who saw Dr. Friedell in 2024. The largest group is 65 to 74, with 81 patients. 72% of them have high blood pressure, and 69% have high cholesterol. 20% are also on Medicaid. Their average risk score is 2.14, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Friedell's median patient age at 73, with 47% women.

In 2024, Dr. Friedell wrote 847 Medicare Part D claims for 218 patients. 83% of them were for generic drugs. CMS names the drug for 607 of them, across 23 drugs with 11 or more claims each, at $360,325 in total drug cost. In 2023, CMS named 560 claims across 21 drugs.

Dr. Friedell accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Friedell as offering telehealth.

CMS Open Payments shows 13 general payments to Dr. Friedell from 10 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 70% of the total. Celgene Corporation paid the most, $65.